REVERE PHARMACEUTICALS
Revere Pharmaceuticals is an oncology-focused biotechnology company leading the development of small molecule therapeutics targeting Rac1 signaling for cancers with unmet clinical needs. Rac1 activity is a key driver of metastatic progression and drug resistance in diverse cancer types. Revere’s lead Rac1 targeted drug candidate is REV-440. The successful development of REV-440 has the potential to provide meaningful clinical impact in multiple refractory cancers characterized by aberrant Rac... 1 signaling. Revere expects REV-440 to enter clinical trials in 2021. Initial clinical development of REV-440 will focus on recurrent ovarian cancer and the critical unmet clinical need of platinum-resistant disease. Treatment of ovarian cancer with REV-440 is supported by compelling preclinical efficacy data. The company was founded in 2016.
REVERE PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Arlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.reverepharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 781 718 9033
Email Addresses:
[email protected]
Total Funding:
4.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Nginx
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Employees Featured
Founder
Official Site Inspections
http://www.reverepharma.com
- Host name: 148.157.199.35.bc.googleusercontent.com
- IP address: 35.199.157.148
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
